A Safety and Efficacy Study to Evaluate AMG 334 in Migraine Prevention
Clinical trial NCT02630459 · COMPLETED
Trial details
- NCT number
- NCT02630459
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-06
- Primary completion
- 2017-09-25
- Enrollment
- 475
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.